Getlabs and Inocras to Streamline Cancer and Disease Testing for Patients
The partnership aims to provide patients with greater accessibility and convenience in accessing whole genome sequencing tests.
Read MorePosted by Andy Lundin | Apr 24, 2024 | Molecular Diagnostics |
The partnership aims to provide patients with greater accessibility and convenience in accessing whole genome sequencing tests.
Read MorePosted by Andy Lundin | Apr 23, 2024 | Anatomic Pathology, Lab Automation |
Mayo Clinic is collaborating with Clarapath to address labor shortages and the increasing volume of tissue specimens in pathology labs.
Read MorePosted by Andy Lundin | Apr 19, 2024 | Immunoassay Instrumentation |
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Cancer |
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read MorePosted by Chris Wolski | Apr 17, 2024 | Womens Health |
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read More